These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31456938)

  • 1. Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review.
    Van Der Weijst L; Lievens Y; Schrauwen W; Surmont V
    Front Oncol; 2019; 9():715. PubMed ID: 31456938
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review.
    Waisberg F; Lopez C; Enrico D; Rodriguez A; Hirsch I; Burton J; Mandó P; Martin C; Chacón M; Seetharamu N
    Crit Rev Oncol Hematol; 2022 Aug; 176():103747. PubMed ID: 35717006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?
    van der Weijst L; Surmont V; Schrauwen W; Lievens Y
    Crit Rev Oncol Hematol; 2017 Nov; 119():40-49. PubMed ID: 29065984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.
    Claassens L; van Meerbeeck J; Coens C; Quinten C; Ghislain I; Sloan EK; Wang XS; Velikova G; Bottomley A
    J Clin Oncol; 2011 May; 29(15):2104-20. PubMed ID: 21464420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review.
    Ter Veer E; van Kleef JJ; Sprangers MAG; Haj Mohammad N; van Oijen MGH; van Laarhoven HWM
    Gastric Cancer; 2018 Mar; 21(2):183-195. PubMed ID: 29380191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding health-related quality of life measures used in early-stage non-small cell lung cancer clinical trials: A review.
    Majem M; Basch E; Cella D; Garon EB; Herbst RS; Leighl NB
    Lung Cancer; 2024 Jan; 187():107419. PubMed ID: 38070301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review.
    Brown T; Pilkington G; Boland A; Oyee J; Tudur Smith C; Dundar Y; Richards E; Yang R; Dickson R
    Health Technol Assess; 2013 Feb; 17(6):1-99. PubMed ID: 23411071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.
    von Verschuer U; Schnell R; Tessen HW; Eggert J; Binninger A; Spring L; Jänicke M; Marschner N;
    Lung Cancer; 2017 Oct; 112():216-224. PubMed ID: 28916198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review.
    Fiteni F; Anota A; Westeel V; Bonnetain F
    BMC Cancer; 2016 Feb; 16():122. PubMed ID: 26892541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC).
    Chayab L; Konstantelos N; Leighl NB; Tadrous M; Wong WWL
    Pharmacoeconomics; 2023 Aug; 41(8):945-980. PubMed ID: 37268866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trials.
    Saad ED; Adamowicz K; Katz A; Jassem J
    Cancer Treat Rev; 2012 Oct; 38(6):807-14. PubMed ID: 22445316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials.
    Bottomley A; Efficace F; Thomas R; Vanvoorden V; Ahmedzai SH
    J Clin Oncol; 2003 Aug; 21(15):2982-92. PubMed ID: 12885819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer.
    Fallowfield LJ; Harper P
    Lung Cancer; 2005 Jun; 48(3):365-77. PubMed ID: 15893006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise intervention to improve exercise capacity and health related quality of life for patients with Non-small cell lung cancer: a systematic review.
    Granger CL; McDonald CF; Berney S; Chao C; Denehy L
    Lung Cancer; 2011 May; 72(2):139-53. PubMed ID: 21316790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
    Kretschmer A; Ploussard G; Heidegger I; Tsaur I; Borgmann H; Surcel C; Mathieu R; de Visschere P; Valerio M; van den Bergh RCN; Marra G; Thibault C; Ost P; Gandaglia G; Tilki D;
    Eur Urol Focus; 2021 Jul; 7(4):742-751. PubMed ID: 32089495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.